ABVC BioPharma, Inc. ABVC
ABVC
ABVC BioPharma, Inc. LIMN
Liminatus Pharma, Inc. Class A Common Stock OTLC
Oncotelic Therapeutics, Inc. INNMF
Amplia Therapeutics Limited JUNS
Jupiter Neurosciences, Inc. FGEN
FibroGen, Inc. RNXT
RenovoRx, Inc. RVPH
Reviva Pharmaceuticals Holdings, Inc. ANVS
Annovis Bio, Inc. ZIVO
ZIVO Bioscience, Inc.
ABVC BioPharma, Inc. LIMN
Liminatus Pharma, Inc. Class A Common Stock OTLC
Oncotelic Therapeutics, Inc. INNMF
Amplia Therapeutics Limited JUNS
Jupiter Neurosciences, Inc. FGEN
FibroGen, Inc. RNXT
RenovoRx, Inc. RVPH
Reviva Pharmaceuticals Holdings, Inc. ANVS
Annovis Bio, Inc. ZIVO
ZIVO Bioscience, Inc.
Performance
| Periode | ABVC | LIMN | OTLC | INNMF | JUNS | FGEN | RNXT | RVPH | ANVS | ZIVO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 232.60 % | -71.86 % | 74.59 % | 173.62 % | 187.92 % | 52.24 % | 43.78 % | -3.68 % | 30.77 % | -12.00 % |
| YTD | 374.26 % | -71.86 % | 164.71 % | 213.66 % | -85.41 % | -20.26 % | -18.38 % | -67.67 % | -66.73 % | -38.52 % |
| 1Y | 508.00 % | -71.86 % | 200.00 % | 21.32 % | -72.13 % | 22.96 % | 11.00 % | -47.16 % | -77.36 % | -34.62 % |
| 3Y | -63.37 % | -71.86 % | 56.88 % | 51.29 % | -72.13 % | -97.26 % | -32.73 % | -83.29 % | -86.54 % | -30.16 % |
| 5Y | -92.67 % | -71.86 % | -52.63 % | -33.63 % | -72.13 % | -99.14 % | -84.71 % | -93.97 % | -65.93 % | 1 366.67 % |
| 10Y | -99.79 % | -71.86 % | -89.89 % | -33.63 % | -72.13 % | -97.94 % | -84.71 % | -93.31 % | -82.27 % | 2 650.00 % |
| Depuis le début | -100.00 % | -71.86 % | -99.99 % | -33.63 % | -72.13 % | -98.08 % | -84.71 % | -93.31 % | -82.27 % | -31.25 % |